Ambipar Emergency Response AMBIQ
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $29.9M
- P/E
- 0.0×
Follow AMBIQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Mar '24 | Jun '24 | Sep '24 | Dec '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | — | — |
P/S ratio |
0.00 | — | — | — | |
P/FCF ratio |
7.69 | — | — | — | |
P/Operating CF |
11.33 | — | — | — | |
P/B ratio |
1.02 | — | — | — | |
Price to Tangible BV |
0.00 | — | — | — | |
EV/Sales |
0.00 | — | — | — | |
EV/EBITDA |
0.00 | — | — | — | |
EV/Operating CF |
5.31 | — | — | — | |
EV/FCF |
16.19 | — | — | — | |
Quick Ratio |
1.94 | 2.09 | 1.88 | — | |
Current Ratio |
2.10 | 2.29 | 2.07 | — | |
Net Debt/EBITDA |
9.00 | 0.00 | 0.00 | — | |
Debt/Assets |
47.43% | 48.12% | 47.29% | 0.00% | |
Debt/Equity |
1.51 | 1.43 | 1.45 | — | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
18.43 | 0.00 | 0.00 | — | |
Capex/Depreciation |
(0.23) | (0.08) | (0.18) | — | |
Interest Coverage |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
1.27% | — | — | — | |
Intangible Assets out of Total Assets |
0.43 | 0.42 | 0.39 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Graham Net Nets |
(1.09) | — | — | — | |
Graham Number |
0.00 | — | — | — | |
Earnings Yield |
(12.40%) | — | — | — | |
Free Cash Flow Yield |
13.00% | — | — | — | |
Revenue per Share |
2.47 | — | — | — | |
Operating CF per Share |
0.46 | 0.00 | 0.00 | — | |
Capex per Share |
(0.05) | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
0.41 | 0.00 | 0.00 | — | |
Cash per Share |
1.94 | 0.00 | 0.00 | — | |
Shareholders Equity per Share |
5.11 | 0.00 | 0.00 | — | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | — | |
Book value per Share |
5.11 | 0.00 | 0.00 | — | |
Free Cash Flow |
22.76 | 5.12 | 48.73 | — | |
Working Capital |
158.29 | 179.04 | 154.61 | — | |
Capital Expenditures |
(2.73) | (1.18) | (7.33) | — | |
Net Current Asset Value |
(314.18) | (313.10) | (333.64) | — | |
EV/EBIT |
6.75 | — | — | — | |
Capex to Sales |
0.02 | 0.00 | 0.00 | — | |
Net Profit Margin |
1.01% | — | — | — | |
Price to Operating Income |
0.00 | — | — | — | |
| Other line items | |||||
Average Receivables |
— | 167.27 | 178.51 | — | |
Average Payables |
17.38 | 29.48 | 28.72 | — | |
Average Inventory |
— | 7.48 | 9.37 | — | |
Average Assets |
479.11 | 808.15 | 866.02 | 413.50 | |
Average Common Equity |
135.07 | 203.73 | 272.15 | — |
Columns are period end dates